Imagion Biosystems Limited today announced “Appendix 3B New issue announcement, application for quotation of additional securities and agreement.”
Read Appendix 3B.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it